Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting
1 clinical trials · Condition
◉ Watch Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting
| Record | Firm | Date |
|---|---|---|
| Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS) (NCT03534635) | Centre Hospitalier Universitaire Vaudois | 2018-06-01 |
Track Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting automatically
Every clearance here is in the API, with alerts when new ones post.